#BEGIN_DRUGCARD DB02798

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H16N5O6P

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(methyl)phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Alpha-Methylene Adenosine Monophosphate

# HET_ID:
ABM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H16N5O6P/c1-23(19,20)21-2-5-7(17)8(18)11(22-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H,19,20)(H2,12,13,14)/t5-,7-,8+,11+/m0/s1

# InChI_Key:
InChIKey=PXSSQXBLDTZHLF-WOIOKPISSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2798

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
345.2484

# Molecular_Weight_Mono:
345.083819781

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DKU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.9

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
3.16e+00 g/l

# Primary_Accession_No:
DB02798

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936495

# PubChem_Substance_ID:
46505912

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00399

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:29 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X16518

# Drug_Target_1_GenBank_ID_Protein:
40218

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
prs

# Drug_Target_1_Gene_Sequence:
>954 bp
ATGTCTAATCAATACGGAGATAAGAATTTAAAGATTTTTTCTTTGAATTCGAATCCAGAG
CTTGCAAAAGAAATCGCAGATATAGTTGGAGTTCAATTAGGGAAATGTTCTGTCACAAGA
TTTAGTGACGGGGAAGTCCAAATTAATATCGAAGAAAGTATTCGCGGATGTGATTGTTAC
ATCATCCAGTCTACAAGTGACCCCGTTAACGAGCATATTATGGAACTGCTGATTATGGTA
GATGCGTTAAAACGCGCTTCTGCAAAAACGATTAACATTGTTATTCCTTATTACGGTTAT
GCGCGTCAAGACAGAAAAGCAAGATCCCGTGAGCCAATCACAGCTAAACTTTTCGCTAAC
CTGCTTGAAACAGCCGGTGCGACTCGTGTGATTGCACTTGACCTGCATGCGCCGCAAATT
CAAGGATTCTTTGATATACCGATTGACCACTTAATGGGTGTTCCGATTTTAGGAGAATAT
TTTGAAGGCAAAAATCTTGAAGATATCGTCATTGTTTCACCAGACCATGGCGGTGTGACA
CGTGCCCGCAAACTGGCTGACCGACTAAAAGCGCCAATTGCGATTATCGATAAACGCCGT
CCGCGTCCAAACGTGGCGGAAGTCATGAATATTGTAGGTAACATCGAAGGGAAGACTGCT
ATCCTCATCGATGACATTATTGATACTGCAGGTACGATTACACTTGCTGCTAATGCGCTC
GTTGAAAACGGAGCGAAAGAAGTATATGCATGCTGTACACACCCTGTACTATCAGGCCCT
GCGGTTGAACGGATTAATAATTCAACAATTAAAGAGCTTGTTGTGACAAACAGCATCAAG
CTTCCTGAAGAAAAGAAAATTGAACGCTTTAAGCAGCTTTCAGTCGGACCGCTTCTGGCC
GAAGCGATTATTCGCGTTCATGAGCAGCAATCAGTCAGCTATCTGTTCAGCTAA

# Drug_Target_1_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_1_General_References:
10742175	Eriksen TA, Kadziola A, Bentsen AK, Harlow KW, Larsen S: Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase. Nat Struct Biol. 2000 Apr;7(4):303-8.
2555671	Nilsson D, Hove-Jensen B, Arnvig K: Primary structure of the tms and prs genes of Bacillus subtilis. Mol Gen Genet. 1989 Sep;218(3):565-71.
7584024	Ogasawara N, Nakai S, Yoshikawa H: Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin. DNA Res. 1994;1(1):1-14.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3047

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34869

# Drug_Target_1_Name:
Ribose-phosphate pyrophosphokinase

# Drug_Target_1_Number_of_Residues:
317

# Drug_Target_1_PDB_ID:
1IBS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_1_Protein_Sequence:
>Ribose-phosphate pyrophosphokinase
MSNQYGDKNLKIFSLNSNPELAKEIADIVGVQLGKCSVTRFSDGEVQINIEESIRGCDCY
IIQSTSDPVNEHIMELLIMVDALKRASAKTINIVIPYYGYARQDRKARSREPITAKLFAN
LLETAGATRVIALDLHAPQIQGFFDIPIDHLMGVPILGEYFEGKNLEDIVIVSPDHGGVT
RARKLADRLKAPIAIIDKRRPRPNVAEVMNIVGNIEGKTAILIDDIIDTAGTITLAANAL
VENGAKEVYACCTHPVLSGPAVERINNSTIKELVVTNSIKLPEEKKIERFKQLSVGPLLA
EAIIRVHEQQSVSYLFS

# Drug_Target_1_Reaction:
ATP + D-ribose 5-phosphate = AMP + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + D-ribose 5-phosphate = AMP + 5-phospho- alpha-D-ribose 1-diphosphate

# Drug_Target_1_SwissProt_ID:
P14193

# Drug_Target_1_SwissProt_Name:
KPRS_BACSU

# Drug_Target_1_Synonyms:
EC 2.7.6.1
P-Rib-PP synthetase
PRPP synthetase
Phosphoribosyl pyrophosphate synthetase
RPPK

# Drug_Target_1_Theoretical_pI:
6.26

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02798
